The page is the record's research on the issuer — no analyst, no rating, no view. # Pelthos Therapeutics Inc. (NYSE: PTHS) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing Pelthos Therapeutics Inc. is listed on the NYSE under the ticker PTHS. Its ISIN is US1711262048. Its LEI is not on the record, as no GLEIF record with the exact legal name in jurisdiction US-NV exists. Its security type is Corporate, its sector is 2836 Biological Products, (No Diagnostic Substances), and its jurisdiction is United States, Nevada. Its segment is not on the record. Its status is listed, not halted. ## The disclosure read The record holds 75 filings in the twelve months to 2026-11-08, across 44 filing days. The median gap between filing days is 5 days. The latest filing is dated 2026-11-03 and is of type regulatory_filing, 5 days before the record date. The NYSE median is 6.0 days for cadence, 64.0 filings and 4.0 days for latency across 3256 issuers. The sector median is 5.5 days for cadence, 65.5 filings and 4.0 days for latency across 176 issuers. Filings by type: 30 directors_dealings, 17 regulatory_filing, 9 results, 6 agm_egm, 5 corporate_news, 5 director_change, 2 prospectus, 1 ad_hoc. ## Auditor The auditor of record is not on the record, as the latest annual report cover carries no dei:AuditorName tag. The auditor's location is not on the record. An auditor change is on the record dated 2026-05-21. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted. ## Orderability The outcome is not determinable under rule version acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, as the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations page as read. The count is 0. ## Open research No openly published research notes were found on the record. The count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer's sealed years are 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 7 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001919246.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NYSE/PTHS (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NYSE/PTHS (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NYSE/PTHS · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp